MedTrace Logo

Femoral Block With or Without Ropivacaine for Analgesia After Total Knee Replacement (TKR)

NCT00910013 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2011-02-28

No results posted yet for this study

Summary

Total knee replacement is a painful procedure. Many solutions have been proposed to diminish the post-operative doses of narcotics, including nerve blocks.

The purpose of the study is to compare if the adjunction of intra-articular ropivacaine to a femoral block is more effective on narcotics consumption than the block alone after TKR.

Conditions

  • Total Knee Replacement

Interventions

DRUG

Ropivacaine

0.5% intra-articular ropivacaïne (20cc)

Sponsors & Collaborators

  • Hopital de l'Enfant-Jesus

    lead OTHER

Principal Investigators

  • Dr Stéphane Pelet, MD,PhD · Hôpital Enfant-Jésus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00910013 on ClinicalTrials.gov